Clinigen K.K. is a fully owned subsidiary of Clinigen plc (listed on London's Alternative Investment Market), a company engaged in a range of pharmaceutical-related business, with its headquarters in Burton-on-Trent, UK. In Japan, Clinigen K.K. works on the development, manufacture and marketing of orphan drugs and pharmaceuticals for niche markets. In collaboration with our fellow group company, Link Healthcare, headquartered in Chuo-ku, Tokyo, Clinigen K.K. provides an early-access program (EAP) for Japanese pharmaceutical manufacturers to supply unapproved drugs for humanitarian use, together with consulting services to facilitate the use of this program.
| Website | http://www.clinigen.co.jp |
| Revenue | $1 million |
| Employees | 2 (2 on RocketReach) |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Roche, GSK, Bristol Myers Squibb, Genentech, Amgen, Teva Pharmaceuticals, Sandoz, Purdue Pharma L.P., Lilly India, Mylan Belgium +45 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Clinigen employee's phone or email?
Clinigen Questions
The Clinigen annual revenue was $1 million in 2026.
Phil O'Connell is the Director of Distribution of Clinigen.
2 people are employed at Clinigen.
The NAICS codes for Clinigen are [325, 32].
The SIC codes for Clinigen are [283, 28].
Top Clinigen Employees
